EU drug regulator approves use of Bavarian Nordic's mpox vaccine, Imvanex for adolescents: Copengagen, Denmark Saturday, September 21, 2024, 10:00 Hrs [IST] Bavarian Nordic A/S, a ...

The European Medicines Agency (EMA) has approved the use of Bavarian Nordic’s mpox vaccine in adolescents, increasing the ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities.

Rwanda has started a vaccination campaign against mpox with 1,000 doses of the vaccine it obtained from Nigeria under an ...

Bavarian's JYNNEOS has also been approved by the U.S. Food and Drug Administration (FDA) but only for adults 18 years and ...

African health-care workers fighting the rapid spread of a virulent mpox strain will learn how to effectively scratch under ...

Mpox, declared a global public health emergency by WHO, has disproportionately affected children and adolescents ...

Mpox (formerly known as monkeypox) is back in the news. As of early September, the World Health Organization has reported ...

The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended an update to Novo Nordisk’s ...

COPENHAGEN, Denmark I 19, 2024 I Bavarian Nordic A/S (OMX: BAVA) announced today that the European Commission has adopted the Committee for ...

The Outsourcing in Clinical Trials New England conference will gather pharma experts to discuss the current clinical trial ...

The Ministry of Health on September 19 announced that it launched an Mpox vaccination campaign for health workers, cross-border business operators, hospitality workers, and other high-risk groups.